The anti-mitochondrial antifungal assay for the discovery and development of new drugs

Bibliography

• Odds FC. Antifungal agents: their diversity and increasing sophistication. Mycologist 2003;6(2):351-5
   Google Scholar
• Andriole VT. Current and future antifungal therapy: new targets for antifungal therapy. Int J Antimicrobial Agents 2000;16:317-21
   PubMed Web of Science ®Google Scholar
• Groll AH, Walsh TJ. Uncommon opportunistic fungi: new nosocomial threats. Clin Microbiol Infect 2001;7(Suppl 2):8-24
   PubMed Web of Science ®Google Scholar
• Groll AH, Kolve H. Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy. Eur J Clin Microbiol Infect Dis 2004;23:256-70
   PubMed Web of Science ®Google Scholar
• Lai CC, Tan CK, Huang YT, Current challenges in the management of invasive fungal infections. J Infect Chemother 2008;14:77-85
   PubMedGoogle Scholar
• Owens JN, Skelley JW, Kyle JA. The fungus among us: an antifungal review. US Pharm 2010;35(8):44-56
   Google Scholar
• Pfaller MA. New developments in the antifungal susceptibility testing of Candida. Curr Fungal Infect Rep 2008;2:125-33
   Google Scholar
• Pfaller MA, Diekema DJ. Epidemiology of invasive mycoses in North America. Crit Rev Microbiol 2010;36:1-53
   PubMed Web of Science ®Google Scholar
• Sundriyal S, Sharma RK, Jain R. Current advances in antifungal targets and drug development. Curr Med Chem 2006;13(11):1321-35
   PubMed Web of Science ®Google Scholar
• Armstrong JS. Mitochondria: a target for cancer therapy. Br J Pharmacol 2006;147:239-48
   PubMed Web of Science ®Google Scholar
• Dykens JA, Will Y. The significance of mitochondrial toxicity testing in drug development. Drug Discov Today 2007;12(17/18):777-85
   PubMed Web of Science ®Google Scholar
• Chan K, Truong D, Shangari N, O'Brien PJ. Drug-induced mitochondrial toxicity. Expert Opin Drug Metab Toxicol 2005;1(4):655-69
   PubMedGoogle Scholar
• Kock JLF, Sebolai OM, Pohl CH, Oxylipin studies expose aspirin as antifungal. FEMS Yeast Res 2007;7:1207-17
   PubMed Web of Science ®Google Scholar
• Kock JLF, Swart CW, Ncango DM, Development of a yeast bio-assay to screen anti-mitochondrial drugs. Curr Drug Disc Technol 2009;6(3):186-91
   PubMedGoogle Scholar
• Samuelsson B, Morgenstern R, Jakobsson P. Membrane prostaglandin E synthase-1: a novel therapeutic agent. Pharm Rev 2007;59:207-24
   PubMed Web of Science ®Google Scholar
• Kock J, Coetzee D, Van Dyk M, Evidence for pharmacologically active prostaglandins in yeasts. SA J Sci 1991;87:73-6
   Web of Science ®Google Scholar
• Alem MAS, Douglas LJ. Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrobial Agents Chemother 2004;(48)1:41-7
   Web of Science ®Google Scholar
• Alem MAS, Douglas LJ. Prostaglandin production during growth of Candida albicans biofilms. J Med Microbiol 2005;54:1001-5
   PubMed Web of Science ®Google Scholar
• Ells R, Kock JLF, Albertyn J, Effect of inhibitors of arachidonic acid metabolism on prostaglandin E2 production by Candida albicans and Candida dubliniensis biofilms. Med Microbiol Immunol 2010;200:23-8
   PubMed Web of Science ®Google Scholar
• Erb-Downward JR, Noverr MC. Characterization of prostaglandin E2 production by Candida albicans. Infect Immun 2007;75:3498-505
   PubMed Web of Science ®Google Scholar
• Noverr MC, Phare SM, Toews GB, Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infect Immun 2001;(69)5:2957-63
   Web of Science ®Google Scholar
• Noverr MC, Toews GB, Huffnagle JB. Production of prostaglandins and leukotrines by pathogenic fungi. Infect Immun 2002;(70)1:400-2
   Web of Science ®Google Scholar
• Noverr MC, Erb-Downward JR, Huffnagle GB. Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes. Clin Microbiol Rev 2003;(16)3:517-33
   Web of Science ®Google Scholar
• Tsitsigiannis DI, Bok J, Andes D, Aspergillus cyclooxygen-like enzymes are associated with prostaglandin production and virulence. Infect Immun 2005;(73)8:4548-59
   Web of Science ®Google Scholar
• Deva R, Ciccoli R, Schewe T, Arachidonic acid stimulates cell growth and forms a novel oxygenated metabolite in Candida albicans. Biochim Biophys Acta 2000;1486:299-311
   PubMed Web of Science ®Google Scholar
• Deva R, Ciccoli R, Kock JLF, Nigam S. Involvement of aspirin-sensitive oxylipins in vulvovaginal candidiasis. FEMS Microbiol Lett 2001;198:37-43
   PubMed Web of Science ®Google Scholar
• Ncango DM, Swart CW, Pohl CH, Mitochondrion activity and dispersal of Aspergillus fumigatus and Rhizopus oryzae. Afr J Microbiol Res 2010;4(9):830-5
   Web of Science ®Google Scholar
• Hiltunen JK, Schonauer, MS, Autio KJ, Mitochondrial fatty acid synthesis type II: more than just fatty acids. J Biol Chem 2009;284(14):9011-15
   PubMed Web of Science ®Google Scholar
• Davis HJ, Sebolai OM, Kock JLF, Lotter AP. Use of non-steroidal anti-inflammatory drugs in the treatment of opportunistic infections. SA Patent Application No. 2009/06259; 2009
   Google Scholar
• Van Dyk MS, Kock JLF, Coetzee DJ, Isolation of a novel arachidonic acid metabolite 3-hydroxy-5,8,11,14-eicosatetraenoic acid (3-HETE) from the yeast Dipodascopsis uninucleata. FEBS Lett 1991;283:195-8
   PubMed Web of Science ®Google Scholar
• Botha A, Kock JLF, Coetzee DJ, The influence of NSAIDs on the life cycle of Dipodascopsis. Syst Appl Microbiol 1992;15:155-60
   Web of Science ®Google Scholar
• Coetzee DJ, Kock JLF, Botha A, Yeast Eicosanoids II. The distribution of arachidonic acid metabolites in the life cycle of Dipodascopsis uninucleata. Syst Appl Microbiol 1992;15:311-18
   Web of Science ®Google Scholar
• Nigam S, Sravan Kumar G, Kock JLF. Biological effects of 3-HETE, a novel compound of the yeast Dipodascopsis uninucleata, on mammalian cells. Prostaglandins Leukot Essent Fatty Acids 1996;55:39
   Google Scholar
• Venter P, Kock JLF, Sravan Kumar G, Production of 3R-hydroxy-polyenoic fatty acids by the yeast Dipodascopsis uninucleata. Lipids 1997;32(12):1277-83
   PubMed Web of Science ®Google Scholar
• Fox S, Ratledge RC, Friend J. Optimisation of 3-hydroxyeicosanoid biosynthesis by the yeast Dipodascopsis uninucleata. Biotech Lett 1997;19:155-8
   Web of Science ®Google Scholar
• Bhatt RK, Falck JR, Nigam S. Enantiospecific total synthesis of a novel arachidonic acid metabolite 3-hydroxy eicosatetraenoic acid. Tet Lett 1998;39:249-52
   Web of Science ®Google Scholar
• Kock JLF, Venter P, Linke D, Biological dynamics and distribution of 3-hydroxy fatty acids in the yeast Dipodascopsis uninucleata as investigated by immunofluorescence microscopy. Evidence for a putative regulatory role in the sexual reproductive cycle. FEBS Lett 1998;472:345-8
   Web of Science ®Google Scholar
• Kock JLF, Van Wyk PWJ, Venter P, An acetylsalicylic acid sensitive aggregation phenomenon in Dipodascopsis uninucleata. Ant van Leeuwenhoek 1999;75:261-6
   PubMed Web of Science ®Google Scholar
• Smith DP, Kock JLF, Van Wyk PWJ, The occurrence of 3-hydroxy-oxylipins in the ascomycetous yeast family Lipomycetaceae. SA J Sci 2000;96:247-9
   Web of Science ®Google Scholar
• Kock JLF, Strauss CJ, Pohl CH, Nigam S. Invited review: The distribution of 3-hydroxy oxylipins in fungi. Prostaglandins Other Lipid Mediat 2003;71:85-96
   PubMed Web of Science ®Google Scholar
• Groza NV, Ivanov IV, Romanov SG, A novel synthesis of 3(R)-HETE, 3(R)HTDE and enzymatic synthesis of 3(R), 15(S)-DiHETE. Tetrahedron 2002;58:9859-63
   Web of Science ®Google Scholar
• Groza NV, Ivanov IV, Romanov SG, Synthesis of tritium labelled 3(R)-HETE and 3(R),18(R/S)-DiHETE through a common synthetic route. J Lab Comp Radiopharm 2004;47:11-17
   Web of Science ®Google Scholar
• Ciccoli R, Sahi S, Singh S, Oxygenation by cyclooxygenase-2 (COX-2) of 3-hydroxyeicosatetraenoic acid (3-HETE), a fungal mimetic of arachidonic acid, produces a cascade of novel bioactive 3-hydroxy-eicosanoids. Biochem J 2005;390:737-47
   PubMed Web of Science ®Google Scholar
• Strauss CJ, Kock JLF, Van Wyk PWJ, Bioactive oxylipins in Saccharomyces cerevisiae. J Inst Brew 2005;111(3):304-8
   Web of Science ®Google Scholar
• Strauss CJ. The role of lipids in the flocculation of Saccharomyces cerevisiae. Ph.D. Dissertation, University of the Free State, South Africa, 2005
   Google Scholar
• Sebolai OM, Pohl CH, Botes PJ, The influence of acetylsalicylic acid on oxylipin migration in Cryptococcus neoformans var. neoformans UOFS Y-1378. Can J Microbiol 2008;54(2):91-6
   PubMed Web of Science ®Google Scholar
• Johnson LV, Walsh ML, Chen LB. Localization of mitochondria in living cells with Rhodamine 123. PNAS 1980;77:990-4
   PubMed Web of Science ®Google Scholar
• Swart CW, Van Wyk PWJ, Pohl CH, Kock JLF. Variation in yeast mitochondrial activity associated with asci. Can J Microbiol 2008;54:532-6
   PubMed Web of Science ®Google Scholar
• Leeuw NJ, Swart CW, Ncango DM, Anti-inflammatory drugs selectively target sporangium development in Mucor. Can J Microbiol 2009;55(12):1392-96
   PubMed Web of Science ®Google Scholar
• Ncango DM. The influence of mitochondrial inhibitors on fungal life cycles. Ph.D. thesis, University of the Free State, Bloemfontein, South Africa, 2011
   Google Scholar
• Costantini P, Jacotot E, Decaudin D, Kroemer G. Mitochondrion as a novel target of anticancer chemotherapy. J Nat Cancer Inst 2000;92:1042-53
   PubMed Web of Science ®Google Scholar
• Swart CW, Swart HC, Coetsee E, 3-D architecture and elemental composition of fluconazole treated yeast asci. Sci Res Essays 2010;5(22):3411-17
   Web of Science ®Google Scholar
• Swart CW, van Wyk PWJ, Pohl CH, Kock JLF. Variation in mitochondrial activity over the life cycle of Nadsonia fulvescens. Afr J Microbiol Res 2010;4(16):1727-32
   Web of Science ®Google Scholar
• Kontoyiannis DP. Modulation of fluconazole sensitivity by the interaction of mitochondria and Erg3p in Saccharomyces cerevisiae. J Antimicrobial Chemother 2000;46:191-97
   PubMed Web of Science ®Google Scholar
• Heinisch JJ. Baker's yeast as a tool for the development of antifungal drugs which target cell integrity. Expert Opin Drug Discov 2008;3(8):931-43
   PubMed Web of Science ®Google Scholar
• Mircus G, Hagag S, Levdansky E, Identification of novel cell wall destabilizing antifungal compounds using a conditional Aspergillus nidulans protein kinase C mutant. J Antimicrob Chemother 2009;64:755-63
   PubMed Web of Science ®Google Scholar
• Hector RF, Braun PC. A 96-well epifluorescence assay for rapid assessment of compounds inhibitory to Candida spp. J Clin Microbiol 1986;24(4):620-24
   PubMed Web of Science ®Google Scholar
• Hawser S, Islam K. Spectrophotometric determination of the morphogenic transformation by synchronous Candida albicans: effects of antifungal agents. J Antimicrob Chemother 1996;38:67-73
   PubMed Web of Science ®Google Scholar
• Krysan DJ, Didone L. A high-throughput screening assay for small molecules that disrupt yeast cell integrity. J Biomol Screen 2008;13:657-64
   PubMed Web of Science ®Google Scholar
• Evans JM, Zaworski PG, Parker CN. A high throughput screen for inhibitors of fungal cell wall synthesis. J Biomol Screen 2002;7(4):359-66
   PubMed Web of Science ®Google Scholar
• Marui J, Yoshimi A, Hagiwara D, Use of Aspergillus oryzae actin gene promoter in a novel reporter system for exploring antifungal compounds and their target genes. Appl Microbiol Biotechnol 2010;87:1829-40
   PubMed Web of Science ®Google Scholar
• Kiso T, Fujita K-I, Ping X, Screening for microtubule-disrupting antifungal agents by using a mitotic-arrest mutant of Aspergillus nidulans and novel action of phenylalanine derivatives accompanying tubulin loss. Antimicrob Agents Chemother 2004;48(5):1739-48
   PubMed Web of Science ®Google Scholar
• Breger J, Fuchs BB, Aperis G, Antifungal chemical compounds identified using a C. elegans pathogenicity assay. Plos Pathogens 2007;3(2):168-78
   Web of Science ®Google Scholar
• Okoli I, Coleman JJ, Tempakakis E, Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay. Plos One 2009;4(9):e7025
   PubMed Web of Science ®Google Scholar
• Pukkila-Worley R, Holson E, Wagner F, Mylonakis E. Antifungal drug discovery through the study of invertebrate model hosts. Curr Med Chem 2009;16(13):1588-95
   PubMed Web of Science ®Google Scholar
• Rea SL, Graham BH, Nakamaru-Ogiso E, Bacteria, yeast, worms, and flies: exploiting simple model organisms to investigate human mitochondrial diseases. Dev Disabil Res Rev 2010;16:200-18
   PubMed Web of Science ®Google Scholar
• Zgoda JR, Porter JR. A convenient microdilution method for screening natural products against bacteria and fungi. Pharmaceutical Biology 2001;39(3):211-25
   Web of Science ®Google Scholar
• Gassner NC, Tamble CM, Bock JE, Accelerating the discovery of biologically active small molecules using a high-throughput yeast halo assay. J Nat Prod 2007;70:383-90
   PubMed Web of Science ®Google Scholar
• Pawar ST, Puranik PR. Screening of terrestrial and freshwater halotolerant cyanobacteria for antifungal activities. World J Microbiol Biotechnol 2008;24:1019-25
   Web of Science ®Google Scholar
• Khan MSA, Ahmad I. Antifungal activity of essential oils and their synergy with fluconazole against drug-resistant strains of Aspergillus fumigatus and Trichophyton rubrum. Appl Microbiol Biotechnol 2011: doi 10.1007/s00253-011-3152-3
   Google Scholar
• Hadacek F, Greger H. Testing of antifungal natural products: methodologies, comparability of results and assay choice. Phytochem Anal 2000;11:137-47
   Web of Science ®Google Scholar
• Neiman AM. Ascospore formation in the yeast Saccharomyces cerevisiae. Microbiol Mol Biol Rev 2005;69(4):565-84
   PubMed Web of Science ®Google Scholar
• Westwood FR, Bigley A, Randall K, Statin-induced muscle necrosis in the rat: distribution, development, and fibre selectivity. Toxicol Pathol 2005;33:246-57
   PubMed Web of Science ®Google Scholar
• Neuzil J, Dyason JC, Freeman R, Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II. J Bioenerg Biomembr 2007;39:65-72
   PubMed Web of Science ®Google Scholar